Skip to main content
. 2024 Dec 2;10(6):00468-2024. doi: 10.1183/23120541.00468-2024

TABLE 1.

Participant demographics

Cohort 1
CHQ development (UK)
Cohort 2
Validation (UK/South Korea)
Cohort 3
Cognitive debrief (UK)
Number 10 535 13
Age, years 63 (55–67) 58 (45–67) 56 (46–70)
Female sex, n (%) 7 (70) 371 (69) 9 (69)
Smoking status, n (%)
 Never 7 (70) 383 (73) 9 (69)
 Ex-smoker 2 (20) 102 (20) 4 (31)
 Current 1 (10) 37 (7) 0 (0)
Duration of cough, months, n (%)
 0 to ≤6 0 214 (41) 0
 6 to ≤12 0 69 (13) 0
 12 to ≤60 3 (30) 146 (28) 6 (46)
 >60 7 (70) 98 (18) 7 (54)
VAS cough severity 74±12 61±20 64±21
LCQ
 Physical 3.5 (2.7–3.9) 4.0 (4.0–5.0) 3.8 (2.7–5.9)
 Psychological 2.1 (1.7–2.6) 4.0 (2.0–4.0) 2.7 (1.9–4.9)
 Social 2.0 (1.8–3.1) 3.0 (2.0–4.3) 2.9 (1.8–4.7)
 Total score 7.5 (6.8–9.0) 11.0 (9.0–13.0) 9.7 (7.1–14.9)
CHQ
 Sensations 4.5 (2.8–5.0) 4 (2–5) 4 (3–5)
 Triggers 9.5 (7.5–12.3) 5 (3–8) 9 (8–12)
 Total score 15 (11–18) 9 (6–12) 14 (12–16)

Data are displayed as mean±sd or median (interquartile range) unless otherwise stated. CHQ: Cough Hypersensitivity Questionnaire (total score range 0–22); VAS: visual analogue scale (range 0–100 mm); LCQ: Leicester Cough Questionnaire (total score range 3–21).